{"id":48606,"date":"2022-09-20T19:01:52","date_gmt":"2022-09-20T17:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alliance-of-wound-care-stakeholders-responds-to-cms-proposed-policy-changes-in-2023-physician-fee-schedule-changes-could-increase-amputations-and-infection-for-patients-with-wounds-restrict-access-t\/"},"modified":"2022-09-20T19:01:52","modified_gmt":"2022-09-20T17:01:52","slug":"alliance-of-wound-care-stakeholders-responds-to-cms-proposed-policy-changes-in-2023-physician-fee-schedule-changes-could-increase-amputations-and-infection-for-patients-with-wounds-restrict-access-t","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alliance-of-wound-care-stakeholders-responds-to-cms-proposed-policy-changes-in-2023-physician-fee-schedule-changes-could-increase-amputations-and-infection-for-patients-with-wounds-restrict-access-t\/","title":{"rendered":"Alliance of Wound Care Stakeholders Responds to CMS Proposed Policy Changes in 2023 Physician Fee Schedule: Changes Could Increase Amputations and Infection for Patients with Wounds, Restrict Access to Care, Impact Reimbursement"},"content":{"rendered":"
\n

BETHESDA, Md.–(BUSINESS WIRE)–The Alliance of Wound Care Stakeholders (The Alliance)<\/a>, a leading voice for wound care advocacy and education to address public policy issues impacting patient access to care, alerted the Centers for Medicare and Medicaid Services (CMS) that changes to the way cellular and\/or tissue-based products for skin wounds (CTPs, also known as \u201cskin substitutes\u201d) are coded and paid for in the physician office under the proposed 2023 Physician Fee Schedule may have unintended consequences of creating barriers to care. Proposed reduced payments for CTPs would not match the costs to physician offices, making these products unaffordable and therefore, unavailable for medically necessary and successful advanced treatments \u2013 potentially increasing amputations and infection for patients with chronic non-healing wounds.\n<\/p>\n

<\/a><\/p>\n

\n\u201cOur comments urge CMS to withdraw or delay implementation of the proposed CTP provisions from the final 2023 Physician Fee Schedule that will be issued this year, giving them the opportunity to further study patient access issues and assess policy implications vetted with key stakeholders,\u201d says Marcia Nusgart, R.Ph., CEO of The Alliance of Wound Care Stakeholders.\n<\/p>\n

\nCMS\u2019 proposed policy reclassifies all CTPs as \u201csupplies incident to a physician service,\u201d and packages payment for these \u201csupplies\u201d into the practice expense associated with that service.\n<\/p>\n

\n\u201cThe impacts are significant to wound care providers and patients on several levels,\u201d says Nusgart, citing several problematic areas.\n<\/p>\n